Arun Raturi
About
Arun Raturi is from Edmonton, Alberta, Canada. Arun works in the following industries: "Biotechnology Research". Arun is currently CSO at Entos Pharmaceuticals, located in Edmonton, Canada Area. Arun also works as Research Associate at University of Alberta, a job Arun has held since Jun 2014. In Arun's previous role as a Senior Research Scientist at Entos Pharmaceuticals, Arun worked in Edmonton, Canada Area until Dec 2017. Prior to joining Entos Pharmaceuticals, Arun was a Scientist at Intas Biopharmaceuticals and held the position of Scientist at Ahmedabad. Prior to that, Arun was a Research Associate at The Scripps Research Institute, based in San Diego, California from Aug 2007 to Jan 2009. Arun started working as Research Associate at Intas Biopharmaceuticals in Ahmedabad Area, India in Apr 2001. From Mar 2000 to Apr 2001, Arun was Research Associate at Wockhardt Research Centre, Aurangabad.
Arun Raturi can be found on Finalscout.com, where members can access Arun Raturi's email for free. Finalscout is a professional database with more than 500 million business professional profiles and 200 million company profiles.
Arun Raturi's current jobs
Use of nanoparticle based novel platforms for the delivery of nucleic acids , small molecules and bio-therapeutics for cancer therapy, vaccines and anti-aging. Specifically, our expertise is in-vivo delivery of non-toxic liposomal formulations of miRNA, mRNA, SiRNA, DNA and crispr.
Study of tumor microenvironment using tools like real-time imaging to decipher the critical steps in cancer progression, with primary focus on angiogenesis.
Arun Raturi's past jobs
Use of nanoparticle based novel platforms for the delivery of nucleic acids , small molecules and bio-therapeutics for cancer therapy, vaccines and anti-aging. Specifically, our expertise is in-vivo delivery of non-toxic liposomal formulations of miRNA, mRNA, SiRNA, DNA and crispr..
Primary responsibility for: 1) Development of screening and neutralizing assays for cancer drugs. The method development, qualification, and validation for bio-molecules were completed and transferred successfully. 2) Development of cell based assay as a replacement of in-vivo assay for the release of drug substance (DS) and drug product (DP) .A robust cell based assay was developed and presently used for release of DS and DP.
Redox interaction between Tissue factor and factor VIIa and its implications in coagulation.
Process optimization (fermentation), Scale-up and early downstream processing of biotherapeutical drugs.
Process optimization (fermentation), Scale-up and early downstream processing of biotherapeutical drugs.